688185 康希诺
已收盘 07-23 15:00:00
资讯
新帖
简况
【百家民企说】康希诺生物朱涛:加大对疫苗创新的投入力度
中新经纬 · 09:51
【百家民企说】康希诺生物朱涛:加大对疫苗创新的投入力度
康希诺: 出口产品为公司的新冠疫苗相关产品,用于支持公司业务在海外其他国家的进一步拓展
证券之星 · 07-22 18:04
康希诺: 出口产品为公司的新冠疫苗相关产品,用于支持公司业务在海外其他国家的进一步拓展
康希诺:出口产品为公司的新冠疫苗相关产品
每日经济新闻 · 07-22 17:17
康希诺:出口产品为公司的新冠疫苗相关产品
南向资金7月16日净卖出康希诺生物13.58万股 连续3日减持
自选股智能写手 · 07-17
南向资金7月16日净卖出康希诺生物13.58万股 连续3日减持
北向资金7月16日净卖出康希诺5.21万股 连续3日减持
自选股智能写手 · 07-17
北向资金7月16日净卖出康希诺5.21万股 连续3日减持
键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司
格隆汇资讯 · 07-16
键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司
康希诺新提交1件商标注册申请
证券之星 · 07-12
康希诺新提交1件商标注册申请
康希诺最新公告:控股股东之一增持公司2万股H股股份
证券之星 · 07-11
康希诺最新公告:控股股东之一增持公司2万股H股股份
康希诺:控股股东之一增持公司2万股H股股份
E公司 · 07-11
康希诺:控股股东之一增持公司2万股H股股份
康希诺股价大幅上涨 获北向资金增持5.20万股
智选洞察 · 07-11
康希诺股价大幅上涨 获北向资金增持5.20万股
一针不到100元?流感疫苗以价换量,智飞生物、康希诺剑指带状疱疹疫苗新蓝海
红刊财经 · 07-09
一针不到100元?流感疫苗以价换量,智飞生物、康希诺剑指带状疱疹疫苗新蓝海
康希诺(688185)7月8日主力资金净卖出658.78万元
证券之星 · 07-09
康希诺(688185)7月8日主力资金净卖出658.78万元
康希诺ESG负责人周靖芸:关注ESG领域议题本质是提升企业核心竞争力
华夏时报网 · 07-08
康希诺ESG负责人周靖芸:关注ESG领域议题本质是提升企业核心竞争力
康希诺大跌5% 北向资金增持24.64万股
智选洞察 · 07-08
康希诺大跌5% 北向资金增持24.64万股
【机构调研记录】广发基金调研震裕科技、康希诺
证券之星 · 07-08
【机构调研记录】广发基金调研震裕科技、康希诺
【机构调研记录】南方基金调研美芯晟、康希诺等3只个股(附名单)
证券之星 · 07-08
【机构调研记录】南方基金调研美芯晟、康希诺等3只个股(附名单)
【私募调研记录】高毅资产调研中国重汽、康希诺
证券之星 · 07-08
【私募调研记录】高毅资产调研中国重汽、康希诺
康希诺(688185)7月5日主力资金净买入135.77万元
证券之星 · 07-06
康希诺(688185)7月5日主力资金净买入135.77万元
康希诺: 公司关注到相关新闻,并愿意积极承担应尽的社会责任
证券之星 · 07-05
康希诺: 公司关注到相关新闻,并愿意积极承担应尽的社会责任
7月5日康希诺涨6.15%,广发科创板两年定开混合基金重仓该股
证券之星 · 07-05
7月5日康希诺涨6.15%,广发科创板两年定开混合基金重仓该股
加载更多
公司概况
公司名称:
康希诺生物股份公司
所属行业:
医药制造业
上市日期:
2020-08-13
主营业务:
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。
发行价格:
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":40.3,"timestamp":1721718000000,"preClose":41.98,"halted":0,"volume":1004004,"delay":0,"floatShares":114999999,"shares":247000000,"eps":-6.1156,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.68,"latestTime":"07-23 15:00:00","open":41.87,"high":42.18,"low":40.26,"amount":41319400,"amplitude":0.0457,"askPrice":40.36,"askSize":2,"bidPrice":40.3,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-6.1156,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":41.98,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":46.18,"lowLimit":37.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"pbRate":1.95,"roa":"--","roe":"--","epsLYR":-6.01,"committee":-0.12605,"marketValue":9972000000,"floatMarketCap":4626000000,"peRate":-6.589705,"changeRate":-0.04,"turnoverRate":0.0087,"status":1,"afterMarket":{"amount":0,"volume":0,"close":40.3,"buyVolume":0,"sellVolume":0,"time":1721720037153,"indexStatus":"已收盘 07-23 15:30:00","preClose":41.98}},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2453462724","title":"【百家民企说】康希诺生物朱涛:加大对疫苗创新的投入力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2453462724","media":"中新经纬","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453462724?lang=zh_cn&edition=full","pubTime":"2024-07-23 09:51","pubTimestamp":1721699482,"startTime":"0","endTime":"0","summary":"近日,康希诺生物首席科学官朱涛在接受中新经纬采访时说。朱涛从事疫苗的研究开发和应用工作长达20年。谈及发展疫苗行业的“新质生产力”,朱涛认为,应该加大对疫苗创新的投入力度,建立完善的创新激励机制,建立疾控、药监和行业协会的联动合作机制,加快为中国和全球提供公共卫生急需疫苗。朱涛表示,疫苗作为直接关系到人民群众生命安全的特殊产品,其生产过程必须严格遵循国家法律法规及相关标准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309522995515aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309522995515aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","06185","688185","159646"],"gpt_icon":0},{"id":"2453575766","title":"康希诺:\n出口产品为公司的新冠疫苗相关产品,用于支持公司业务在海外其他国家的进一步拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2453575766","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453575766?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:04","pubTimestamp":1721642687,"startTime":"0","endTime":"0","summary":"康希诺董秘:尊敬的投资人您好,相较于传统技术路线,腺病毒载体技术路线可快速响应研发及产品制备,具体可参考公司于2020年全球公共卫生事件初期的响应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200024968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185","159646"],"gpt_icon":0},{"id":"2453751480","title":"康希诺:出口产品为公司的新冠疫苗相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2453751480","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453751480?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:17","pubTimestamp":1721639836,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:您好,据海关数据显示,五月份天津出口疫苗100多万,请问,是贵司的疫苗出口吗?如是,是什么疫苗品种?康希诺(688185.SH)7月22日在投资者互动平台表示,出口产品为公司的新冠疫苗相关产品,用于支持公司业务在海外其他国家的进一步拓展。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221717449ede8a7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221717449ede8a7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","06185","159646","BK0239"],"gpt_icon":0},{"id":"2452979640","title":"南向资金7月16日净卖出康希诺生物13.58万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452979640","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452979640?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:31","pubTimestamp":1721179890,"startTime":"0","endTime":"0","summary":"7月16日,南向资金减持康希诺生物13.58万股连续3日减持。截止当日收盘,港股通共持有康希诺生物4903.36万股,占流通股36.95%。港股通减持金额前五个股分别为美团-W、中国宏桥、中国海洋石油、汇丰控股、腾讯控股。康希诺生物近5个交易日上涨1.61%,港股通累计减持19.26万股;近20个交易日下跌10.87%,港股通累计减持9.26万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170947009f5a24d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170947009f5a24d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK0239","688185"],"gpt_icon":0},{"id":"2452621979","title":"北向资金7月16日净卖出康希诺5.21万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452621979","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452621979?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:30","pubTimestamp":1721179837,"startTime":"0","endTime":"0","summary":"7月16日,北向资金减持康希诺5.21万股连续3日减持。截止当日收盘,沪股通共持有康希诺121.95万股,占流通股1.06%。沪股通减持金额前五个股分别为中国平安、中国银行、XD工商银、招商银行、工业富联。康希诺近5个交易日上涨1.57%,沪股通累计增持2.39万股;近20个交易日下跌12.57%,沪股通累计减持35.66万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071709372795cb8034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071709372795cb8034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185","06185"],"gpt_icon":0},{"id":"2451951722","title":"键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2451951722","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451951722?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:35","pubTimestamp":1721115331,"startTime":"0","endTime":"0","summary":"格隆汇7月16日丨键凯科技(688356.SH)在投资者互动平台表示,公司与康希诺合作开发的三组分LNP可授权给其他公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161535389f546cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161535389f546cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1574","BK1161","688356","06185","688185"],"gpt_icon":0},{"id":"2450732723","title":"康希诺新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2450732723","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450732723?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:05","pubTimestamp":1720760736,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日康希诺生物股份公司新提交1件商标注册申请。商标申请详情如下:今年以来康希诺生物股份公司新申请注册商标40件,截止目前公司共持有注册商标176件,另有92件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200023282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2450355906","title":"康希诺最新公告:控股股东之一增持公司2万股H股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355906","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450355906?lang=zh_cn&edition=full","pubTime":"2024-07-11 19:30","pubTimestamp":1720697427,"startTime":"0","endTime":"0","summary":"康希诺公告,公司控股股东之一、董事长兼总经理XUEFENGYU(宇学峰)增持了公司2万股H股股份。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100037493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2450330908","title":"康希诺:控股股东之一增持公司2万股H股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2450330908","media":"E公司","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450330908?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:51","pubTimestamp":1720695060,"startTime":"0","endTime":"0","summary":"e公司讯,康希诺(688185)7月11日晚间公告,公司控股股东之一、董事长兼总经理XUEFENGYU(宇学峰)增持了公司2万股H股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711185137aef935cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711185137aef935cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","06185","688185","BK1574","BK1161"],"gpt_icon":0},{"id":"2450870330","title":"康希诺股价大幅上涨 获北向资金增持5.20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450870330","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450870330?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:11","pubTimestamp":1720663862,"startTime":"0","endTime":"0","summary":"07月11日,康希诺股价大幅上涨,截至10点11分,康希诺上涨5.23%,报41.45元/股,突破40元整数关口,成交2696万元,换手率0.58%,振幅3.78%。资金动向截止发稿,康希诺获得主力净流出325万元,其中超大单流出305万元,大单流出19万元。北向资金方面,康希诺07月10日获得北向资金增持5.20万股,截至07月10日,北向资金当前共持有康希诺124.77万股,市值5171万元,持股占流通股比为1.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101127aef91a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101127aef91a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2450304826","title":"一针不到100元?流感疫苗以价换量,智飞生物、康希诺剑指带状疱疹疫苗新蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2450304826","media":"红刊财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450304826?lang=zh_cn&edition=full","pubTime":"2024-07-09 19:21","pubTimestamp":1720524060,"startTime":"0","endTime":"0","summary":"三价和四价流感疫苗都可有效起到预防效果,公众可自愿接种任意一种流感疫苗。不押宝流感疫苗“红海”智飞生物、康希诺等聚焦带状疱疹、流脑结合疫苗实际上,在流感疫苗中角逐的并非仅仅这四家,从2023年的签批情况来看,其中还有长春生物、百克生物、天元生物、中慧元通、赛诺菲巴斯德等公司也最终榜上有名。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709191951941f56a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709191951941f56a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0188","LU1064131003.USD","LU1328615791.USD","06185","BK0077","BK0196","300122","BK0046","LU1064130708.USD","159646","LU2148510915.USD","BK0239"],"gpt_icon":0},{"id":"2450032026","title":"康希诺(688185)7月8日主力资金净卖出658.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450032026","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450032026?lang=zh_cn&edition=full","pubTime":"2024-07-09 08:22","pubTimestamp":1720484549,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月8日收盘,康希诺报收于40.11元,下跌4.7%,换手率1.2%,成交量1.38万手,成交额5642.75万元。近5日资金流向一览见下表:康希诺融资融券信息显示,融资方面,当日融资买入289.2万元,融资偿还301.11万元,融资净偿还11.92万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900011878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2449706522","title":"康希诺ESG负责人周靖芸:关注ESG领域议题本质是提升企业核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706522","media":"华夏时报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449706522?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:47","pubTimestamp":1720446441,"startTime":"0","endTime":"0","summary":"康希诺 ESG负责人周靖芸从企业实践出发,分享了公司在A股和 H股 两地监管下企业ESG领域业绩提升的相关策略。周靖芸进一步表示,上市公司应该以定期报告编制为抓手,将ESG理念深入到公司具体的工作实施以及集团化的管理当中,以最终提升公司的管治水平、披露透明度和核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082153379f1eff38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082153379f1eff38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","688185","BK1161","06185","BK1574"],"gpt_icon":0},{"id":"2449741429","title":"康希诺大跌5% 北向资金增持24.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449741429","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449741429?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:44","pubTimestamp":1720421063,"startTime":"0","endTime":"0","summary":"07月08日,康希诺股价大幅下跌,截至14点44分,康希诺下跌5.01%,报39.98元/股,失守40元整数关口,成交5240万元,换手率1.11%。资金动向截止发稿,康希诺获得主力净流出481万元,其中超大单流出840万元,大单流入360万元。北向资金方面,康希诺07月05日获得北向资金增持24.64万股,截至07月05日,北向资金当前共持有康希诺145.70万股,市值5825万元,持股占流通股比为1.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708144433af90fe3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708144433af90fe3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2449079166","title":"【机构调研记录】广发基金调研震裕科技、康希诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2449079166","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449079166?lang=zh_cn&edition=full","pubTime":"2024-07-08 08:01","pubTimestamp":1720396912,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月5日披露的机构调研信息,广发基金近期对2家上市公司进行了调研,相关名单如下:1)震裕科技 个股亮点:震裕转债于2023-11-09上市;公司与宁德时代开展战略合作,逐渐成为宁德时代重要的结构件供应商之一。;公司开展16种创新疫苗产品的研发广发基金成立于2003年,截至目前,资产管理规模12880.55亿元,排名3/204;资产管理规模7227.81亿元,排名3/204;管理公募基金数730只,排名2/204;旗下公募基金经理84人,排名8/204。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800000588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300953","BK0239","688185"],"gpt_icon":0},{"id":"2449791540","title":"【机构调研记录】南方基金调研美芯晟、康希诺等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2449791540","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449791540?lang=zh_cn&edition=full","pubTime":"2024-07-08 08:01","pubTimestamp":1720396894,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月5日披露的机构调研信息,南方基金近期对3家上市公司进行了调研,相关名单如下:1)美芯晟 个股亮点:公司的主要产品包括高集成度MCU数字控制SoC电源--无线充电芯片,以及模拟电源--LED照明驱动芯片。;公司开展16种创新疫苗产品的研发3)路维光电 个股亮点:公司是大尺寸铬版光罩领域领先企业。旗下最近一年表现最佳的公募基金产品为南方融尚再融资混合,最新单位净值为1.84,近一年增长37.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080803089f1aeb95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080803089f1aeb95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","06185","688185","BK1574","BK1161"],"gpt_icon":0},{"id":"2449791547","title":"【私募调研记录】高毅资产调研中国重汽、康希诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2449791547","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449791547?lang=zh_cn&edition=full","pubTime":"2024-07-08 08:00","pubTimestamp":1720396847,"startTime":"0","endTime":"0","summary":"根据市场公开信息及7月5日披露的机构调研信息,知名私募高毅资产近期对2家上市公司进行了调研,相关名单如下:1)中国重汽 个股亮点:公司借助于山东重工集团在氢能源产业中的技术及资源优势,已在氢能源重卡方面具备充分的技术储备,氢能源产品的核心布局和整车集成开发已经全面完成;公司具有车用减速驱动桥产品。高毅资产旗下汇聚了多位长期业绩优秀、市场经验丰富的明星投资经理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708080112958cb269&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708080112958cb269&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","03808","BK1171","BK1548","LU0287142896.SGD","SG9999011746.SGD","LU0173614495.USD","688185"],"gpt_icon":0},{"id":"2449249442","title":"康希诺(688185)7月5日主力资金净买入135.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449249442","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449249442?lang=zh_cn&edition=full","pubTime":"2024-07-06 08:11","pubTimestamp":1720224715,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月5日收盘,康希诺报收于42.09元,上涨6.15%,换手率1.92%,成交量2.2万手,成交额9083.01万元。近5日资金流向一览见下表:康希诺融资融券信息显示,融资方面,当日融资买入326.29万元,融资偿还682.61万元,融资净偿还356.32万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070600012981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2449426353","title":"康希诺:\n公司关注到相关新闻,并愿意积极承担应尽的社会责任","url":"https://stock-news.laohu8.com/highlight/detail?id=2449426353","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449426353?lang=zh_cn&edition=full","pubTime":"2024-07-05 19:03","pubTimestamp":1720177406,"startTime":"0","endTime":"0","summary":"证券之星消息,康希诺07月05日在投资者关系平台上答复投资者关心的问题。谢谢康希诺董秘:尊敬的投资人您好,关于公司定期报告截止日及其后的股东人数提问,公司执行的一贯标准是,定期报告截止日及其后的股东人数披露,不早于当期定期报告的披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500040649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","161912","BK0239"],"gpt_icon":0},{"id":"2449533132","title":"7月5日康希诺涨6.15%,广发科创板两年定开混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449533132","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449533132?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:15","pubTimestamp":1720167321,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日康希诺涨6.15%创60日新低,收盘报42.09元,换手率1.92%,成交量2.2万手,成交额9083.01万元。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为广发科创板两年定开混合。广发科创板两年定开混合目前规模为2.99亿元,最新净值0.6264,较上一交易日下跌1.73%,近一年下跌30.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051619489f093c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051619489f093c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1515","BK1574","688185","BK1161","BK1191"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","stockEarnings":[{"period":"1week","weight":0.0453},{"period":"1month","weight":-0.0492},{"period":"3month","weight":-0.1335},{"period":"6month","weight":-0.2797},{"period":"1year","weight":-0.4614},{"period":"ytd","weight":-0.4367}],"companyName":"康希诺生物股份公司","boardCode":"AI0027","perCapita":"5647股","boardName":"医药制造业","registeredCapital":"24744万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。","serverTime":1721745373938,"listedPrice":209.71,"stockholders":"20323人(较上一季度减少0.67%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}